AIDP, Inc. revealed the recent publication of the 30-day clinical investigation on the safety and efficacy of KollaGen II-xs, a specialized collagen type II hydrolysate. This dietary ingredient distributed by AIDP had been shown to support joint health, including range of motion, general pain and muscle strength. It is shown to be safe and efficacious in reducing symptoms of joint discomfort, and joint and cartilage disorders, according to the company.
 
The study, entitled “A 30-day clinical investigation of the efficacy of KollaGen II-xs, a new avian sternal collagen type II hydrolysate,” was recently published in the peer-reviewed journal HealthMED.
 
The results of the study indicate that the administration of 1500mg of avian sternal collagen type II hydrolysate daily ingested over 30 days is safe and efficacious in reducing symptoms of joint discomfort. Seventy-eight percent of the individuals at the end of the study noticed substantial improvement in relief of symptoms, including range of motion, pain and muscle strength.
 
AIDP’s Vice President of R&D, Dr. Jennifer Gu stated: “Kollagen II-xs contains important glycosaminoglycans (GAGs), including chondroitin sulfate and hyaluronic acid, and can stimulate chondrocytes to produce collagen type II. Kollagen II XS is unique as it contains all the important components of cartilage: collagens and GAGs (chondroitin, hyaluronic acid) in a ratio similar to that in joint cartilage, thus providing a synergistic effect for cartilage rebuild.”
 
For more information: http://aidp.com